22 results
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
Topical drug formulations ... #pharmacology #table ... medications #comparison #drugs ... #treatment #pharmacotherapy
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
#medications #table ... #treatment #drugs ... #pharmacotherapy
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
are usually the drugs ... Drug interactions ... depending on the drug ... pharmacology #comparison #treatment ... #table #pharmacotherapy
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #pharmacology #treatment ... #medications #table ... #pharmacotherapy ... decisionaid #cardiology #hematology
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
sequestration and activation ... : 33% • Treatment ... , and CXR with pulmonary ... : No • Treatment ... diagnosis #comparison #table
Treatment of Obstructive Sleep Apnea
Positive airway pressure therapy
   → Positive pharyngeal transmural pressure
Treatment of Obstructive ... unfavorable collapse on drug-induced ... sleep endoscopy Pharmacotherapy ... Obstructive #SleepApnea #Treatment ... #management #pulmonary
Hyponatremia - Differential Diagnosis by Mechanism
Decr Blood Pressure (“Decr Effective Circulating Volume”) 
 - Volume depletion
the lung) - CNS ... hemorrhage) - Pulmonary ... exacerbation) - Drugs ... Differential #Diagnosis #Table
Approach to Eosinophilic Lung Diseases
 • Acute Eosinophilic Pneumonia (< 1 wk) - ~30yo, M; Recent
, wt loss; CV, CNS ... Fever, wheezing • Drug ... antibiotics, illicit drugs ... Lung #Diseases #pulmonary ... diagnosis #comparison #table
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Activation of CD8 ... IFN-y) → Excessive activation ... immune deficiency, Drugs ... Unknown cause Treatment ... #summary #rheumatology
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
Macrophage Activation ... nervous system (CNS ... ) • Sepsis • Drug-induced ... Treatment: • Corticosteroids ... #Rheumatology